Identification of mpox M1R and B6R monoclonal and bispecific antibodies that efficiently neutralize authentic mpox virus
In 2022, the monkeypox virus (mpox virus, MPXV) exhibited global dissemination across six continents, representing a notable challenge owing to the scarcity of targeted antiviral interventions.Passive immunotherapy, such as the use of Slippery Elm monoclonal antibodies (mAbs) and bispecific antibodies (bsAbs), has emerged as a promising option for